4.6 Review

Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Nitric oxide regulation of cellular metabolism: Adaptive tuning of cellular energy

Gregory Pappas et al.

Summary: This review summarizes the effects of nitric oxide (NO) on various metabolic processes, including glycolysis, fatty acid metabolism, the TCA cycle, and oxidative phosphorylation. Moderate NO concentrations upregulate glucose and fatty acid oxidation, while higher concentrations shift cellular reliance toward glycolysis. Moderate NO production improves mitochondrial efficiency and whole-body energy production.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Nicotinamide as potential biomarker for Alzheimer's disease: A translational study based on metabolomics

Maria C. Dalmasso et al.

Summary: This study found significant differences in plasma levels of nicotinamide (Nam) between Alzheimer's disease (AD) patients and cognitively normal individuals, suggesting its potential use as a biomarker for AD progression. The decrease in Nam plasma levels was observed a couple of years before conversion to AD.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Review Clinical Neurology

Huntington's disease: diagnosis and management

Thomas B. Stoker et al.

Summary: Huntington's disease is an inherited neurodegenerative disease characterized by neuropsychiatric symptoms, movement disorder, and progressive cognitive impairment. Diagnosis is usually confirmed through genetic testing, but atypical presentations can make it challenging to determine disease progression. Current treatments are symptomatic, with limited evidence supporting their efficacy.

PRACTICAL NEUROLOGY (2022)

Article Clinical Neurology

Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease

Emrin Horgusluoglu et al.

Summary: This study aims to identify AD-specific metabolomic changes and their potential upstream genetic and transcriptional regulators through an integrative systems biology framework. The findings suggest that short-chain acylcarnitines/amino acids and medium/long-chain acylcarnitines are most associated with AD clinical outcomes. Integration of gene expression data reveals ABCA1 and CPT1A are involved in regulating acylcarnitines and amino acids in AD.

ALZHEIMERS & DEMENTIA (2022)

Article Neurosciences

Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor

Elena A. Ostrakhovitch et al.

Summary: Parkinson's disease and essential tremor are two common adult-onset tremor disorders. This study found significant metabolic differences in plasma and cerebrospinal fluid between these two diseases.

NEUROSCIENCE LETTERS (2022)

Review Biochemistry & Molecular Biology

Update on CSF Biomarkers in Parkinson's Disease

Eun Hae Kwon et al.

Summary: This paper emphasizes the importance of reliable objective markers for identifying individuals at risk of Parkinson's disease. Advances in biomarker discovery, particularly in the cerebrospinal fluid (CSF), have provided promising preliminary results. Potential biomarkers include alpha-synuclein species, markers of amyloid and tau pathology, neurofilament light chain, lysosomal enzymes, and markers of neuroinflammation. Metabolomics approaches have also offered insights into novel biological pathways. Genetic forms of PD can help identify subgroups suitable for targeted treatments. Further validation studies are needed to determine the most valuable CSF biomarkers or combinations for clinical and research purposes.

BIOMOLECULES (2022)

Article Cell Biology

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease

Brage Brakedal et al.

Summary: In this study, we found that oral intake of nicotinamide riboside (NR) in Parkinson's disease (PD) patients was safe and increased cerebral NAD levels, leading to altered cerebral metabolism and mild clinical improvement. NR also upregulated processes related to mitochondrial, lysosomal, and proteasomal function in blood cells and/or skeletal muscle, and decreased the levels of inflammatory cytokines.

CELL METABOLISM (2022)

Article Neurosciences

Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites

Karel Kalecky et al.

Summary: In this study, metabolic changes in Alzheimer's disease (AD) were investigated in plasma and frontal brain cortex tissue samples, revealing disturbances in multiple pathways including microbiome-related metabolites, methylhistidine metabolism, polyamines, and lipids. Elevated triglycerides were observed in plasma of AD patients, while altered amino acid metabolism was found in the cortex. Plasma metabolites showed potential as biomarkers for predicting AD, with specific accuracy for females. Targeting multiple metabolic areas, including microbiome composition and hormonal balance, may offer new intervention strategies for AD.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Article Agriculture, Dairy & Animal Science

Application of an optimized and validated LC-MS/MS method for the quantification of free 3-nitrotyrosine in plasma, urine and liver tissue of lactating dairy cows

D. Barcarolo et al.

Summary: In dairy cows, oxidative stress during the transition period can be influenced by environmental conditions such as heat stress. A study developed and validated a method for accurate determination of 3-NT in blood, urine, and liver samples in dairy cows using LC-MS/MS. Results showed higher 3-NT concentrations in cows that gave birth during spring, along with higher BHBA and lower glucose concentrations. Liver TAG content and aspartate transaminase activity were also higher in cows that gave birth during spring.

LIVESTOCK SCIENCE (2022)

Article Neurosciences

Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease

Tapan Behl et al.

Summary: In the past decade, researchers have found that seemingly unrelated neurodegenerative disorders, such as Parkinson's disease, share remarkable cellular and molecular biology similarities. Protein misfolding and aggregation play a role in all of these diseases, leading to the formation of inclusion bodies in cells. The discovery of disease-causing gene alterations related to the ubiquitin-proteasome pathway proteins in Parkinson's disease has strengthened the connection between this pathway and neurodegeneration. However, the specific molecular linkages between these systems and the pathogenesis of these diseases are still unknown and controversial.

MOLECULAR NEUROBIOLOGY (2022)

Review Endocrinology & Metabolism

Metabolic changes favor the activity and heterogeneity of reactive astrocytes

Xiao-Yi Xiong et al.

Summary: This review discusses the function of reactive astrocytes under pathological conditions and summarizes the emerging roles of glucose and lipid metabolism in reactive astrocytes in the context of CNS injury, offering new insights into the metabolic mechanisms of neuroprotection or damage mediated by reactive astrocytes.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2022)

Article Medical Informatics

Application of 3D Whole-Brain Texture Analysis and the Feature Selection Method Based on within-Class Scatter in the Classification and Diagnosis of Alzheimer's Disease

Ke Zhou et al.

Summary: This study used three-dimensional texture features and employed an embedded feature selection method based on least squares loss and within-class scatter to analyze MRI images of MCI patients and predict the likelihood of their conversion to AD. The results indicate that the feature selection algorithm used is effective.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2022)

Article Pharmacology & Pharmacy

Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease

Zhao Dai et al.

Summary: This study conducted a comprehensive metabolomics analysis on AD animal models and patients, revealing key metabolites and pathways, and predicting potential protein markers. The findings are of great significance for understanding the pathological mechanism of AD.

FRONTIERS IN PHARMACOLOGY (2022)

Article Cell Biology

Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer's Disease

Magdalena Mroczek et al.

Summary: This study identified cerebrospinal fluid proteome alterations associated with neuropsychiatric symptoms (NPS). These alterations are related to the pathophysiology of Alzheimer's disease (AD) and cognitive decline, and may represent independent processes from AD. Furthermore, some of these protein changes were found to be associated with accelerated cognitive decline.

CELLS (2022)

Article Neurosciences

Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson's disease

Yi Zhang et al.

Summary: Disturbances of plasma BCAAs and AAAs in PD patients may be related to the gut microbiota and exacerbated with PD severity.

NPJ PARKINSONS DISEASE (2022)

Article Multidisciplinary Sciences

APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes

Joel W. Blanchard et al.

Summary: APOE4 has widespread effects on gene expression in the human brain, particularly in relation to cholesterol homeostasis and transport. Aberrant cholesterol deposition in oligodendrocytes leads to reduced myelination, while pharmacologically facilitating cholesterol transport improves learning and memory. This study provides insights into the impact of APOE4 on the aging human brain and suggests potential therapeutic strategies for Alzheimer's disease.

NATURE (2022)

Article Endocrinology & Metabolism

Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease

Zhenzhen Yan et al.

Summary: Gastrointestinal symptoms in early-stage Parkinson's disease (PD) may be associated with alterations in gut microbiome and serum amino acid levels. This study found that the relative abundance of certain microbial taxa and serum amino acid levels were significantly different in a PD mouse model induced with rotenone compared to the control group. Furthermore, the altered serum amino acid levels were closely related to the abundance of specific gut microbiota. The findings suggest a potential role of the gut-microbiota-metabolite axis in early-stage PD and provide insights for future prevention and treatment strategies.

METABOLIC BRAIN DISEASE (2022)

Article Cell Biology

Branched-Chain Amino Acids Are Linked with Alzheimer's Disease-Related Pathology and Cognitive Deficits

Md Abu Bakkar Siddik et al.

Summary: This study reveals a positive association between circulating BCAAs and AD. BCAAs may impair neuronal functions, while BCAA-lowering can alleviate AD-related pathology and cognitive decline, establishing a potential causal link between BCAAs and AD progression.

CELLS (2022)

Article Biochemistry & Molecular Biology

Plasma Metabolic Disturbances in Parkinson's Disease Patients

Paulina Gatarek et al.

Summary: Plasma metabolome analysis can provide valuable information on altered metabolites in patients with Parkinson's disease (PD). This study identified a panel of metabolites that could discriminate PD from controls with high accuracy and revealed metabolic pathways associated with the pathophysiology of PD.

BIOMEDICINES (2022)

Article Biochemistry & Molecular Biology

Metabolomics of blood reveals age-dependent pathways in Parkinson's Disease

Nicola D'Ascenzo et al.

Summary: This study identified PD blood metabolites and metabolic pathways significantly correlated with age, and proposed a personalized age-dependent approach to early PD diagnosis.

CELL AND BIOSCIENCE (2022)

Review Biochemistry & Molecular Biology

Genetic Basis of the Epidemiological Features and Clinical Significance of Renal Hypouricemia

Masayuki Hakoda et al.

Summary: A genetic defect in URAT1 is the main cause of renal hypouricemia. The prevalence of mutant URAT1 alleles is around 0.1% in Japan and 3% in the general population. Exercise-induced acute kidney injury is more common in individuals with homozygous/compound heterozygous URAT1 mutations.

BIOMEDICINES (2022)

Article Cell Biology

Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation

Sai S. Pradhan et al.

Summary: This study analyzed metabolomics data from HD patients and a yeast model of HD, and found a considerable overlap of deregulated metabolic pathways. The multiomics analysis also revealed common and unique deregulated pathways in human, mice, and yeast model systems. The modulation of these deregulated pathways was shown to influence protein aggregation in HD through the addition of certain metabolites and gene knockouts in the yeast model system. These findings highlight the importance of regulating deregulated pathways in HD for protein aggregation, disease progression, and prognosis.

DISEASE MODELS & MECHANISMS (2022)

Article Biochemistry & Molecular Biology

Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress

Saikat Dewanjee et al.

Summary: This article systematically evaluates the abnormal glucose metabolism associated with amyloid beta and phosphorylated tau accumulation in AD, and discusses the role of insulin signaling and mitochondrial dysfunction in the progression of AD pathology.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Review Biochemistry & Molecular Biology

Microwave Radiation and the Brain: Mechanisms, Current Status, and Future Prospects

Sohail Mumtaz et al.

Summary: Modern humans are exposed to various radiations daily, and the brain is the most sensitive organ to electromagnetic radiation (EMR) exposure. However, there are still many unknown factors in related studies, including the effects of different parameters and irradiation time. This review analyzes and interprets recent studies on the effects of microwave radiation on learning and memory capabilities in the brain, as well as the mechanisms of brain dysfunction caused by exposure, providing prospective views for future research in developing preventive and therapeutic strategies for brain degeneration caused by microwave radiation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Neurodegenerative Diseases: Can Caffeine Be a Powerful Ally to Weaken Neuroinflammation?

Melania Ruggiero et al.

Summary: Coffee consumption with its bioactive compounds has shown to benefit human health and reduce the risk of neurodegenerative diseases. Neuroinflammation plays a critical role in the development of these diseases. Controlled caffeine delivery systems can help maintain high plasma caffeine levels for extended periods.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Clinical Neurology

Uric Acid in Parkinson's Disease: What Is the Connection?

Fatemeh Seifar et al.

Summary: Numerous studies have found an association between low levels of uric acid (UA) and Parkinson's disease (PD), suggesting that low UA may contribute to oxidative stress and the degeneration of dopamine neurons, leading to the onset and progression of PD symptoms. However, recent research has raised questions about this explanation, proposing that low UA may be a biomarker rather than a causative factor for PD.

MOVEMENT DISORDERS (2022)

Article Multidisciplinary Sciences

Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer's disease (from the Nakayama Study)

Tomoki Ozaki et al.

Summary: Alzheimer's disease (AD) is a progressive disease with metabolomic abnormalities playing a role in the development of AD and mild cognitive impairment (MCI). This study aimed to identify metabolomic biomarkers related to AD and MCI by comparing different groups of patients. The results showed significant differences in plasma metabolites such as ornithine, uracil, and lysine among the groups. Furthermore, the study found correlations between metabolites and clinical symptoms, as well as changes in mRNA expressions related to ornithine metabolism in AD patients. The study suggests a potential association between abnormal ornithine metabolism and AD, and highlights the relevance of betaine and methionine in predicting the functional ability of elderly individuals.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington's Disease

Marta Tomczyk et al.

Summary: In this study, the effects of rosiglitazone on grip strength and heart function in an experimental HD model were tested. It was found that rosiglitazone treatment improved grip strength and cardiac mechanical function in R6/1 mice by enhancing cellular energetics.

CELLS (2022)

Article Endocrinology & Metabolism

Metabolomic Profiling of Peripheral Plasma by GC-MS and Correlation With Size of Uterine Leiomyomas

Gustavo Anderman Silva Barison et al.

Summary: This study evaluated the circulating metabolites in the plasma of patients with uterine leiomyomas and their correlation with the presence and size of the tumors. The results showed differences in plasma levels of amino acids, fatty acids, and carbohydrates among patients with leiomyomas, with most of them being reduced but some significantly increased in sizeable leiomyomas.

JOURNAL OF THE ENDOCRINE SOCIETY (2022)

Article Neurosciences

Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry

Yaping Shao et al.

Summary: This study used a liquid chromatography-high resolution mass spectrometry-based metabolomics approach to comprehensively evaluate metabolic disturbances in PD, identifying potential metabolic biomarkers and confirming a metabolite panel for improved diagnosis of PD.

MOLECULAR NEURODEGENERATION (2021)

Review Biochemistry & Molecular Biology

Crosstalk between Neuron and Glial Cells in Oxidative Injury and Neuroprotection

Kyung Hee Lee et al.

Summary: This article discusses the role of glia in protecting neurons from oxidative injury and maintaining antioxidant defense mechanisms in the brain, as well as the essential crosstalk between glia and neurons to maintain redox balance for protection against oxidative stress.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Clinical Neurology

Periphery and brain, innate and adaptive immunity in Parkinson's disease

Ashley S. Harms et al.

Summary: Parkinson's disease involves both neuronal events and a significant immune component, with changes in the immune system occurring in both the central nervous system and the periphery. Alpha-synuclein plays a crucial role in activating the innate and adaptive immune system, contributing to neuronal degeneration and symptomatology in patients.

ACTA NEUROPATHOLOGICA (2021)

Review Biochemistry & Molecular Biology

What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease

Lukasz Przybyl et al.

Summary: Developing therapeutic strategies for HD requires the development of biomarkers for assessing treatment efficacy, with symptoms in peripheral tissues serving as indicators. Investigation of inflammatory proteins and immune cells in HD can provide insights into disease pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article

Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer’s Disease

Oluyomi Stephen Adeyemi et al.

Oxidative Medicine and Cellular Longevity (2021)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Review Nutrition & Dietetics

Methylxanthines and Neurodegenerative Diseases: An Update

Daniel Janitschke et al.

Summary: Methylxanthines have various beneficial effects, including bronchoprotective, anti-inflammatory and antioxidant properties, regulation of lipid homeostasis, and neuroprotective effects. They impact multiple pathways associated with diseases, making them an interesting approach in dealing with neurodegenerative diseases.

NUTRIENTS (2021)

Article Immunology

Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis

Fan Yang et al.

Summary: This study identified differential metabolic profiles in Chinese patients with MS, including changes in amino acids, lipids, and carbohydrates. Amino acids showed a noticeable decrease while lipid and carbohydrate metabolites increased. Levels of proinflammatory cytokines were significantly elevated, while concentrations of anti-inflammatory cytokines and chemokines were reduced. Certain metabolites showed a clear negative correlation with inflammatory factors, providing potential insights for future therapeutic strategies for MS.

FRONTIERS IN IMMUNOLOGY (2021)

Article Neurosciences

Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study

Wenna Duan et al.

Summary: This longitudinal study examined rCBF changes in different groups of NC, MCI, and AD participants using perfusion MRIs with ASL. Baseline rCBF values in specific brain regions were found to predict 3MSE scores at follow-up, indicating the potential for early prediction of cognitive decline and AD conversion using perfusion MRI biomarkers.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Biochemistry & Molecular Biology

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease

Filipe B. Rodrigues et al.

Summary: This study measured KP metabolites in the cerebrospinal fluid and plasma of HD patients and found that these metabolites can be reliably quantified in both biofluids in controls and HD gene expansion carriers. However, the research did not find significant differences in levels of metabolites in patient-derived biofluids and these metabolites were not associated with clinical or imaging measures.

JOURNAL OF NEUROCHEMISTRY (2021)

Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Article Clinical Neurology

Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease

Isidro Ferrer et al.

Summary: The study found abnormal protein phosphorylation at the early stages of NFT pathology in the elderly and sporadic Alzheimer's disease (sAD), with protein phosphorylation abnormalities in the FC preceding the formation of NFTs and SPs. The most active period of dysregulated phosphorylation is at stages III-IV, when some individuals may be classified clinically as having mild cognitive impairment, which is a precursor stage in the progression to dementia.

BRAIN PATHOLOGY (2021)

Article Cell Biology

Brain glycogen serves as a critical glucosamine cache required for protein glycosylation

Ramon C. Sun et al.

Summary: This study demonstrates the connection between N-linked protein glycosylation and glucosamine metabolism in the brain, where glucosamine acts as an abundant constituent of brain glycogen for glycoconjugates. The enzymatic mechanisms of glucosamine incorporation and release in glycogen were validated, revealing that disruption of brain glycogen metabolism leads to decreased levels of UDP-N-acetylglucosamine and N-linked protein glycosylation.

CELL METABOLISM (2021)

Review Medical Laboratory Technology

Biosensors in Parkinson's disease

Ahmad Mobed et al.

Summary: Parkinson's disease is a critical disorder affecting the elderly worldwide, with over six million people impacted. Advances in electrochemical techniques offer promising tools for PD diagnosis and monitoring.

CLINICA CHIMICA ACTA (2021)

Review Pharmacology & Pharmacy

Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review

Rachel Litke et al.

Summary: This study presents evidence of modifiable factors of Alzheimer disease and related dementias in a life-course approach, identifying factors that could be protective or deleterious for the diseases based on the time of exposure in life, offering opportunities for therapeutic and preventive actions.

CLINICAL THERAPEUTICS (2021)

Review Biochemistry & Molecular Biology

Purine Nucleotides Metabolism and Signaling in Huntington's Disease: Search for a Target for Novel Therapies

Marta Tomczyk et al.

Summary: Huntington's disease (HD) is a multi-system disorder caused by expanded CAG repeats in the HTT gene, affecting gene transcription, endocytosis, and metabolism. This study explores the modulation of the purinergic system as a therapeutic target in HD, focusing on the impact of impaired nucleotide metabolism on purine signaling in affected systems like the CNS, skeletal muscle, and heart. Compounds that reconstruct the purine and ATP pools, along with purinergic receptor activity modulators such as P2X7 receptor antagonists, show promise for HD treatment based on the collected findings.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Neurosciences

A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease

Federica Cioffi et al.

Summary: Oxidative stress is closely associated with the progression of Alzheimer's disease, leading to modifications in lipids, DNA, RNA, and proteins in the brain. Various biomarkers have been developed to identify oxidative stress levels in AD, but they may not differentiate well from other neurodegenerative disorders. Redox proteomics approaches provide specificity in identifying oxidative stress-associated biomarkers specific to AD pathology.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Review Neurosciences

Glucose metabolic crosstalk and regulation in brain function and diseases

Shuai Zhang et al.

Summary: Glucose metabolism in the brain is essential for providing energy and building blocks for biological processes. Different cell types within the brain have specific profiles of glucose metabolism, which are regulated by signal transduction proteins. Dysfunction in glucose metabolism is closely linked to neurological diseases, emphasizing the importance of understanding and targeting these metabolic networks for therapeutic interventions.

PROGRESS IN NEUROBIOLOGY (2021)

Article Public, Environmental & Occupational Health

The impact of long-term care service on total lifetime medical expenditure among older adults with dementia

Sungje Moon et al.

Summary: This study aimed to estimate the lifetime medical expenditures of older adults with dementia and investigate the effectiveness of long-term care insurance in reducing their expenses. The findings showed that dementia patients had significantly higher medical expenditures compared to those without dementia, and the use of long-term care services had a positive effect on reducing medical expenses.

SOCIAL SCIENCE & MEDICINE (2021)

Review Genetics & Heredity

The Genetics of Parkinson's Disease and Implications for Clinical Practice

Jacob Oliver Day et al.

Summary: The genetic landscape of Parkinson's disease includes rare high penetrance pathogenic variants, genetic risk factor variants, and high frequency, low penetrance variants which contribute to the risk of developing the disease. Understanding these influences can have a major impact on the clinical care of PD patients.

GENES (2021)

Review Biochemistry & Molecular Biology

Mitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration

Juan A. Godoy et al.

Summary: Mitochondria play critical roles in neurons by regulating neurotransmission and synaptic plasticity through ATP supply, calcium homeostasis, redox balance control, and apoptosis. Their functional integrity is mainly maintained by mitostasis, involving processes like mitochondrial transport, anchoring, fusion, and fission, regulated by various signaling pathways. The communication between mitochondria and the endoplasmic reticulum (ER) via mitochondria-associated membranes (MAMs) is crucial for Ca2+ buffering. Alterations in mitochondrial activity can lead to increased production of reactive oxygen species, disturbance in physiological metabolism, and mitochondrial dysfunction resulting in cell death through apoptosis.

BIOMOLECULES (2021)

Review Clinical Neurology

The Alzheimer's Disease Amyloid Precursor Protein and its Neuritogenic Actions

Luan Luu et al.

Summary: The Amyloid Precursor Protein (APP) is primarily known for its role in Alzheimer's disease, but it also plays important physiological roles within the nervous system, including neurogenesis, synaptic plasticity, and neuroprotection. Understanding the normal functions of APP is essential for understanding its role in both health and Alzheimer's disease.

CURRENT ALZHEIMER RESEARCH (2021)

Review Cell Biology

Autophagy in healthy aging and disease

Yahyah Aman et al.

Summary: This Review discusses the recent research on the mechanisms and roles of autophagy in health, aging, and disease, and how drugs modulating autophagy process could be used to suppress age-associated diseases. It examines emerging features of autophagy and proposes the potential links to aging and disease progression. The review also highlights the importance of understanding the interplay between autophagy and age-related pathologies for the development of clinical applications promoting long-term health.

NATURE AGING (2021)

Article Clinical Neurology

Disease Onset in Huntington's Disease: When Is the Conversion?

Mayke Oosterloo et al.

Summary: This study aimed to explore the accuracy of diagnostic confidence level in estimating disease onset in Huntington's disease using the Enroll-HD data set. Results showed that baseline diagnostic confidence levels were significantly higher in converters compared to non-converters, indicating that the diagnostic confidence level may not be an accurate instrument to determine phenoconversion, and more reliable diagnostic criteria are needed for evaluating disease modifying therapies.

MOVEMENT DISORDERS CLINICAL PRACTICE (2021)

Article Neurosciences

Impaired metabolism of kynurenine and its metabolites in CSF of parkinson's disease

Kazuhiro Iwaoka et al.

NEUROSCIENCE LETTERS (2020)

Review Neurosciences

β-Amyloid Peptide: the Cell Compartment Multi-faceted Interaction in Alzheimer's Disease

Pasquale Picone et al.

NEUROTOXICITY RESEARCH (2020)

Article Biochemical Research Methods

GC-MS Based Metabolic Profiling of Parkinson's Disease with Glutathione S-transferase M1 and T1 Polymorphism in Tunisian Patients

Amal Rebai et al.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2020)

Review Biochemistry & Molecular Biology

Mitochondrial OXPHOS Biogenesis: Co-Regulation of Protein Synthesis, Import, and Assembly Pathways

Jia Xin Tang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Neurosciences

Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances

Wenzhang Wang et al.

MOLECULAR NEURODEGENERATION (2020)

Review Biotechnology & Applied Microbiology

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

Stephen C. Cunnane et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Biochemistry & Molecular Biology

Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington's Disease Status Based on Omics Data

Christiana C. Christodoulou et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia

Maria Ricci et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Physiology

Transport of Amino Acids Across the Blood-Brain Barrier

Rosa Zaragoza

FRONTIERS IN PHYSIOLOGY (2020)

Review Clinical Neurology

Role of homocysteine in the development and progression of Parkinson's disease

Xiaoyan Fan et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Review Biochemistry & Molecular Biology

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases

Nicole Jacqueline Jensen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Comprehensive Review on Alzheimer's Disease: Causes and Treatment

Zeinab Breijyeh et al.

MOLECULES (2020)

Article Nutrition & Dietetics

Review of Lysine Metabolism with a Focus on Humans

Dwight E. Matthews

JOURNAL OF NUTRITION (2020)

Article Biochemistry & Molecular Biology

The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease

Ian F. Harrison et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Article Public, Environmental & Occupational Health

Association Between Serum β-Alanine and Risk of Dementia The Hisayama Study

Jun Hata et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2019)

Article Biochemistry & Molecular Biology

Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity

Maria S. Ioannou et al.

Article Endocrinology & Metabolism

How glycogen sustains brain function: A plausible allosteric signaling pathway mediated by glucose phosphates

Mauro DiNuzzo

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)

Review Clinical Neurology

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

Yu Yamazaki et al.

NATURE REVIEWS NEUROLOGY (2019)

Article Clinical Neurology

Dysbiosis of gut microbiota in a selected population of Parkinson's patients

Daniele Pietrucci et al.

PARKINSONISM & RELATED DISORDERS (2019)

Review Neurosciences

α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies

Michael X. Henderson et al.

NEUROSCIENCE LETTERS (2019)

Article Clinical Neurology

Systemic and central nervous system metabolic alterations in Alzheimer's disease

Vera van der Velpen et al.

ALZHEIMERS RESEARCH & THERAPY (2019)

Review Physiology

Branched Chain Amino Acids

Michael Neinast et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)

Review Immunology

Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target

Freek J. H. Sorgdrager et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease

Jing Zhi A. Tan et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2019)

Review Pharmacology & Pharmacy

Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease

Fanni A. Boros et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2019)

Review Neurosciences

Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease

Yaping Shao et al.

MOLECULAR NEURODEGENERATION (2019)

Review Biochemistry & Molecular Biology

Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis

Jessika P. Teixeira et al.

MOLECULES (2019)

Article Clinical Neurology

Deutetrabenazine in the treatment of Huntington's disease

Alby Richard et al.

NEURODEGENERATIVE DISEASE MANAGEMENT (2019)

Article Endocrinology & Metabolism

Brain Fuel Utilization in the Developing Brain

Pascal Steiner

ANNALS OF NUTRITION AND METABOLISM (2019)

Review Clinical Neurology

Huntington's disease: a clinical review

P. McColgan et al.

EUROPEAN JOURNAL OF NEUROLOGY (2018)

Article Clinical Neurology

Evidence for brain glucose dysregulation in Alzheimer's disease

Yang An et al.

ALZHEIMERS & DEMENTIA (2018)

Review Biochemistry & Molecular Biology

Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration

Mariana Pehar et al.

ANTIOXIDANTS & REDOX SIGNALING (2018)

Review Cell Biology

The concept of alpha-synuclein as a prion-like protein: ten years after

Jennifer A. Steiner et al.

CELL AND TISSUE RESEARCH (2018)

Review Medical Laboratory Technology

Glycophagy: An emerging target in pathology

Hong Zhao et al.

CLINICA CHIMICA ACTA (2018)

Review Neurosciences

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis

Maria Bjerke et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Review Neurosciences

Mitochondria and Mitochondrial Cascades in Alzheimer's Disease

Russell H. Swerdlow

JOURNAL OF ALZHEIMERS DISEASE (2018)

Review Neurosciences

Mitochondrial calcium imbalance in Parkinson's disease

Marthe H. R. Ludtmann et al.

NEUROSCIENCE LETTERS (2018)

Article Geriatrics & Gerontology

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease

Daniel Stoessel et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

Review Clinical Neurology

On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease

Nicolas Giguere et al.

FRONTIERS IN NEUROLOGY (2018)

Review Cell Biology

Intercellular Spread of Protein Aggregates in Neurodegenerative Disease

Albert A. Davis et al.

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 34 (2018)

Article Biochemical Research Methods

Norepinephrine stimulates glycogenolysis in astrocytes to fuel neurons with lactate

Jay S. Coggan et al.

PLoS Computational Biology (2018)

Article Multidisciplinary Sciences

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease

Desiree Willkommen et al.

PLOS ONE (2018)

Review Neurosciences

A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward

Edina Silajdzic et al.

JOURNAL OF HUNTINGTONS DISEASE (2018)

Article Biochemistry & Molecular Biology

β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms

Lavanya B. Achanta et al.

NEUROCHEMICAL RESEARCH (2017)

Article Biochemistry & Molecular Biology

Fats for thoughts: An update on brain fatty acid metabolism

Adele Romano et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)

Article Clinical Neurology

Epidemiology of Parkinson's disease

Ole-Bjorn Tysnes et al.

JOURNAL OF NEURAL TRANSMISSION (2017)

Article Biochemistry & Molecular Biology

Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia

Jesper F. Havelund et al.

JOURNAL OF NEUROCHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Branched-Chain Amino Acids and Brain Metabolism

Justin E. Sperringer et al.

NEUROCHEMICAL RESEARCH (2017)

Article Clinical Neurology

Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins

William P. Flavin et al.

ACTA NEUROPATHOLOGICA (2017)

Article Clinical Neurology

Metabolic network failures in Alzheimer's disease: A biochemical road map

Jon B. Toledo et al.

ALZHEIMERS & DEMENTIA (2017)

Article Biochemistry & Molecular Biology

Striatal synaptic dysfunction and altered calcium regulation in Huntington disease

Lynn A. Raymond

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Review Cell Biology

Brain fluorodeoxyglucose (FDG) PET in dementia

Takashi Kato et al.

AGEING RESEARCH REVIEWS (2016)

Review Biochemistry & Molecular Biology

8-Hydroxy-2-Deoxyguanosine Levels and Cardiovascular Disease: A Systematic Review and Meta-Analysis of the Literature

Alessandro Di Minno et al.

ANTIOXIDANTS & REDOX SIGNALING (2016)

Article Biochemistry & Molecular Biology

Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain

Stefano Patassini et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Article Biochemistry & Molecular Biology

An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington's disease related cardiomyopathy

Marta Toczek et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Review Biochemistry & Molecular Biology

NAD+ metabolism: Bioenergetics, signaling and manipulation for therapy

Yue Yang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2016)

Review Biochemistry & Molecular Biology

The clinical symptoms of Parkinson's disease

Sigurlaug Sveinbjornsdottir

JOURNAL OF NEUROCHEMISTRY (2016)

Review Biochemistry & Molecular Biology

Mitochondrial dysfunction in Parkinson's disease

Anindita Bose et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Biochemical Research Methods

Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism

Giuseppe Paglia et al.

JOURNAL OF PROTEOME RESEARCH (2016)

Article Biochemical Research Methods

Novel Metabolite Biomarkers of Huntington's Disease As Detected by High-Resolution Mass Spectrometry

Stewart F. Graham et al.

JOURNAL OF PROTEOME RESEARCH (2016)

Article Clinical Neurology

Polyneuropathy in levodopa-treated Parkinson's patients

Karol Szadejko et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)

Article Neurosciences

Post-translational modification of α-synuclein in Parkinson's disease

Paul J. Barrett et al.

BRAIN RESEARCH (2015)

Article Chemistry, Analytical

Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease

Raul Gonzalez-Dominguez et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Article Clinical Neurology

Huntington Disease Pathogenesis and Treatment

Praveen Dayalu et al.

NEUROLOGIC CLINICS (2015)

Article Medicine, General & Internal

White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease

Lauren P. Klosinski et al.

EBIOMEDICINE (2015)

Review Neurosciences

S-Nitrosylation in Alzheimer's disease

Qing-Fei Zhao et al.

MOLECULAR NEUROBIOLOGY (2015)

Article Clinical Neurology

A systems-level misunderstanding: the plasma metabolome in Huntington's disease

Herminia D. Rosas et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Review Clinical Neurology

Metabolism in HD: Still a Relevant Mechanism?

Wenzhen Duan et al.

MOVEMENT DISORDERS (2014)

Review Clinical Neurology

Treatment of Huntington's Disease

Samuel Frank

NEUROTHERAPEUTICS (2014)

Review Biotechnology & Applied Microbiology

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease

Anmu Xie et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Clinical Neurology

Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls

Markus J. Schwarz et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)

Letter Multidisciplinary Sciences

Properties of native brain α-synuclein Reply

Tim Bartels et al.

NATURE (2013)

Review Neurosciences

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

Sudhakar Raja Subramaniam et al.

PROGRESS IN NEUROBIOLOGY (2013)

Article Clinical Neurology

Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease

Alastair J. Noyce et al.

ANNALS OF NEUROLOGY (2012)

Review Cardiac & Cardiovascular Systems

Advantages and disadvantages of PET and SPECT in a busy clinical practice

Timothy M. Bateman

JOURNAL OF NUCLEAR CARDIOLOGY (2012)

Article Biotechnology & Applied Microbiology

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease

Monika Bialecka et al.

PHARMACOGENETICS AND GENOMICS (2012)

Article Clinical Neurology

Cerebral amyloid angiopathy in the elderly

Anand Viswanathan et al.

ANNALS OF NEUROLOGY (2011)

Review Cell Biology

Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation

Mireille Belanger et al.

CELL METABOLISM (2011)

Article Biochemistry & Molecular Biology

HD CAG-correlated gene expression changes support a simple dominant gain of function

Jessie C. Jacobsen et al.

HUMAN MOLECULAR GENETICS (2011)

Article Biochemistry & Molecular Biology

Ubiquitin-dependent mitochondrial protein degradation

Jin-Mi Heo et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)

Review Clinical Neurology

Development of biomarkers for Huntington's disease

David W. Weir et al.

LANCET NEUROLOGY (2011)

Article Clinical Neurology

Serum levels of N-acetylaspartate in Huntington's disease: Preliminary results

Maddalena Ruggieri et al.

MOVEMENT DISORDERS (2011)

Review Clinical Neurology

Histamine in the regulation of wakefulness

Mahesh M. Thakkar

SLEEP MEDICINE REVIEWS (2011)

Article Clinical Neurology

DISABILITY AND PROGRESSION IN PARKINSON'S DISEASE

Reijo J. Marttila et al.

ACTA NEUROLOGICA SCANDINAVICA (2010)

Article Clinical Neurology

Decreased plasma alanine and isoleucine in Huntington's disease

R. Reilmann et al.

ACTA NEUROLOGICA SCANDINAVICA (2010)

Article Cell Biology

Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1

Chuang-Rung Chang et al.

MITOCHONDRIAL RESEARCH IN TRANSLATIONAL MEDICINE (2010)

Review Cell Biology

The dysregulation of intracellular calcium in Alzheimer disease

Charlene Supnet et al.

CELL CALCIUM (2010)

Review Immunology

Regulation of inflammasome activity

Greta Guarda et al.

IMMUNOLOGY (2010)

Article Endocrinology & Metabolism

Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy

Fawzi Boumezbeur et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)

Article Biochemistry & Molecular Biology

Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease

Caroline M. Forrest et al.

JOURNAL OF NEUROCHEMISTRY (2010)

Article Neurosciences

Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease

Marta Martinez-Vicente et al.

NATURE NEUROSCIENCE (2010)

Article Clinical Neurology

Glycogen metabolism Metabolic coupling between astrocytes and neurons

Eduardo E. Benarroch

NEUROLOGY (2010)

Review Endocrinology & Metabolism

Insulin signaling meets mitochondria in metabolism

Zhiyong Cheng et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)

Article Clinical Neurology

Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration

Elisabeth Andreadou et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2009)

Article Genetics & Heredity

Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors

M. Futter et al.

JOURNAL OF MEDICAL GENETICS (2009)

Article Biochemistry & Molecular Biology

Direct measurement of oxidative metabolism in the living brain by microdialysis: a review

H. Ronald Zielke et al.

JOURNAL OF NEUROCHEMISTRY (2009)

Article Multidisciplinary Sciences

Energy-Efficient Action Potentials in Hippocampal Mossy Fibers

Henrik Alle et al.

SCIENCE (2009)

Article Neurosciences

Complex I deficiency in Parkinson's disease frontal cortex

W. Davis Parker et al.

BRAIN RESEARCH (2008)

Article Medicine, General & Internal

A review of Parkinson's disease

C. A. Davie

BRITISH MEDICAL BULLETIN (2008)

Review Pharmacology & Pharmacy

Adenosine as a neuromodulator in neurological diseases

Detlev Boison

CURRENT OPINION IN PHARMACOLOGY (2008)

Article Neurosciences

Mitochondrial transport proteins of the brain

D. A. Berkich et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2007)

Article Biochemistry & Molecular Biology

Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients

Chiung-Mei Chen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Review Neurosciences

N-acetylaspartate in the CNS:: From neurodiagnostics to neurobiology

John R. Moffett et al.

PROGRESS IN NEUROBIOLOGY (2007)

Review Biochemistry & Molecular Biology

Tauopathies

F. Hernandez et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2007)

Review Biochemistry & Molecular Biology

Extracellular NAD and ATP: Partners in immune cell modulation

Friedrich Haag et al.

PURINERGIC SIGNALLING (2007)

Review Biochemistry & Molecular Biology

Mitochondrial Aβ:: A potential cause of metabolic dysfunction in Alzheimer's disease

Xi Chen et al.

IUBMB LIFE (2006)

Article Psychiatry

Seeing is believing: neuroimaging adds to our understanding of cerebral pathology

Gary W. Small et al.

CURRENT OPINION IN PSYCHIATRY (2006)

Review Medicine, Research & Experimental

AMP-activated protein kinase signaling in metabolic regulation

Yun Chau Long et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Biochemistry & Molecular Biology

Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction

A Goswami et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Multidisciplinary Sciences

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease

F Borovecki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Biochemistry & Molecular Biology

Monocarboxylate transporters in the central nervous system: distribution, regulation and function

K Pierre et al.

JOURNAL OF NEUROCHEMISTRY (2005)

Article Nutrition & Dietetics

Glutathione metabolism and its implications for health

GY Wu et al.

JOURNAL OF NUTRITION (2004)

Article Multidisciplinary Sciences

Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo

Y Itoh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)